|
MechanismAHL synthase inhibitors |
|
|
|
Inactive Indication- |
Drug Highest PhasePreclinical |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with Khatam Al-Nabieen University
0 Patents (Medical) associated with Khatam Al-Nabieen University
100 Deals associated with Khatam Al-Nabieen University
100 Translational Medicine associated with Khatam Al-Nabieen University